Latest News
All Times Eastern
- Bond yields steady before payrolls after week of big price gains
- These analysts say the office and apartment building worries after NYCB are like Groundhog Day — but do concede one issue
- Car loaded with gas in Kenya explodes and sets off inferno that injures more than 270, kills at least 33
- Barron's Energy Stocks Have Struggled. Why They Shine as Dividend Payers.
- Barron's Philip Morris Stock Stands to Get a Boost From Earnings
- Barron's Brazil Is Having a Great Time. 5 Stocks to Play.
- Barron's Boeing’s Troubles Aren’t Going Away. How to Profit From Its Problems.
- Barron's The 6% Commission for Home Sales Is Under Attack. Inside the Fight to Keep It Alive.
- Prosecutors weigh perjury charge for ex-Trump CFO Allen Weisselberg over civil fraud trial testimony
- Shares of China’s Landsea Green rise on plan to buy Texas homebuilder for $185 million
to be replaced
Merck & Co. Inc.
MRKUS
$
0.02
0.02%
Premarket
$
126.40
Before Hours Volume:
53
| Close | Chg | Chg % |
|---|---|---|
| $126.38 | 5.60 | 4.64% |
Volume: 11.65M
65 Day Avg: 8.4M
122.77
Day Range
126.43
99.14
52 Week Range
126.43
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
MRK Overview
Key Data
- Open $123.65
- Day Range 122.77 - 126.43
- 52 Week Range 99.14 - 126.43
- Market Cap $306.06B
- Shares Outstanding 2.53B
- Public Float 2.53B
- Beta 0.51
- Rev. per Employee N/A
- P/E Ratio 955.98
- EPS $0.13
- Yield 2.44%
- Dividend $0.77
- Ex-Dividend Date Mar 14, 2024
- Short Interest 20.81M 01/12/24
- % of Float Shorted 0.82%
- Average Volume 8.4M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 28
Full Ratings
Recent News
Biotech and Pharma Merck Stock Gains on Surprise Profit and Impressive Guidance
Biotech and Pharma Merck and J&J’s Biotech Deals Are More Good News for a Troubled Sector
Biotech and Pharma The Pandemic’s Impact on Merck Is Lessening, CFO Says
Vanguard Health Care Fund's Strategic Moves: A Deep Dive into Vertex Pharmaceuticals' Position ...
Vanguard Health Care Fund's Strategic Moves: A Deep Dive into Vertex Pharmaceuticals' Position ...
on GuruFocus.com
Why Merck Stock Rocketed Nearly 5% Skyward Today
on Motley Fool
Merck (MRK) Q4 2023 Earnings Call Transcript
on Motley Fool
Merck (NYSE:MRK) Delivers Better-than-Expected Results in Q4
on TipRanks.com
Merck (MRK) Beats Q4 Earnings Estimates
on Zacks.com
Earnings Scheduled For February 1, 2024
on Benzinga.com
Wall Street Analysts Are Bullish on Top Healthcare Picks
on TipRanks.com
Powell Dubious on March Cut, Markets Slide
on Zacks.com
Merck & Co's Earnings: A Preview
on Benzinga.com
Merck (MRK): Quarterly Earnings - What Investors Should Know
on StockNews.com
Merck & Co. Inc.
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Johnson & Johnson | $382.52B | |
| Pfizer Inc. | $152.9B | |
| Novo Nordisk A/S | kr.3.47T | |
| Eli Lilly & Co. | $612.88B | |
| Abbott Laboratories | $196.44B | |
| Novartis AG | CHF184.9B | |
| Bristol Myers Squibb Co. | $99.44B | |
| Sanofi S.A. | €117.31B | |
| Zoetis Inc. | $86.23B | |
| GSK PLC | £64.15B |